BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31635050)

  • 21. SUMO regulates p21Cip1 intracellular distribution and with p21Cip1 facilitates multiprotein complex formation in the nucleolus upon DNA damage.
    Brun S; Abella N; Berciano MT; Tapia O; Jaumot M; Freire R; Lafarga M; Agell N
    PLoS One; 2017; 12(6):e0178925. PubMed ID: 28582471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SRC-3, a Steroid Receptor Coactivator: Implication in Cancer.
    Li L; Deng CX; Chen Q
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear accumulation of UBC9 contributes to SUMOylation of lamin A/C and nucleophagy in response to DNA damage.
    Li Y; Jiang X; Zhang Y; Gao Z; Liu Y; Hu J; Hu X; Li L; Shi J; Gao N
    J Exp Clin Cancer Res; 2019 Feb; 38(1):67. PubMed ID: 30744690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells.
    Bozickovic O; Skartveit L; Engelsen AST; Helland T; Jonsdottir K; Flågeng MH; Fenne IS; Janssen E; Lorens JB; Bjørkhaug L; Sagen JV; Mellgren G
    J Steroid Biochem Mol Biol; 2019 Jan; 185():57-70. PubMed ID: 30048685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription.
    Chien CD; Kirilyuk A; Li JV; Zhang W; Lahusen T; Schmidt MO; Oh AS; Wellstein A; Riegel AT
    J Biol Chem; 2011 Jul; 286(30):26813-27. PubMed ID: 21636853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
    Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.
    Janssen K; Hofmann TG; Jans DA; Hay RT; Schulze-Osthoff K; Fischer U
    Oncogene; 2007 Mar; 26(11):1557-66. PubMed ID: 16924230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
    Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
    Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PML Bodies in Mitosis.
    Lång A; Lång E; Bøe SO
    Cells; 2019 Aug; 8(8):. PubMed ID: 31416160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Puromycin induces SUMO and ubiquitin redistribution upon proteasome inhibition.
    Matsumoto H; Saitoh H
    Biochem Biophys Res Commun; 2016 Jul; 476(3):153-8. PubMed ID: 27181354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome.
    Li X; Lonard DM; Jung SY; Malovannaya A; Feng Q; Qin J; Tsai SY; Tsai MJ; O'Malley BW
    Cell; 2006 Jan; 124(2):381-92. PubMed ID: 16439211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1.
    Anzick SL; Azorsa DO; Simons SS; Meltzer PS
    BMC Cancer; 2003 Sep; 3():22. PubMed ID: 12964942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection and Application of DNA Aptamer Against Oncogene Amplified in Breast Cancer 1.
    An Y; Wu J; Yang B; Zhu Z; Gao M; Yu C; Yang CJ
    J Mol Evol; 2015 Dec; 81(5-6):179-85. PubMed ID: 26458993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
    Shah YM; Rowan BG
    Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
    Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
    Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of PML nuclear bodies in CBP degradation through the ubiquitin-proteasome pathway.
    St-Germain JR; Chen J; Li Q
    Epigenetics; 2008 Nov; 3(6):342-9. PubMed ID: 19011377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment.
    Jaber BM; Mukopadhyay R; Smith CL
    J Mol Endocrinol; 2004 Feb; 32(1):307-23. PubMed ID: 14766010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
    Doucas V; Tini M; Egan DA; Evans RM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2627-32. PubMed ID: 10077561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
    Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy-related intrinsically disordered proteins in intra-nuclear compartments.
    Na I; Meng F; Kurgan L; Uversky VN
    Mol Biosyst; 2016 Aug; 12(9):2798-817. PubMed ID: 27377881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.